Preclinical common data elements for general pharmacological studies (pharmacokinetic sample collection, tolerability, and drug administration). A report of the TASK3‐WG1A General Pharmacology Working Group of the ILAE/AES Joint Translational Task Force

Abstract Growing concerns over rigor and reproducibility of preclinical studies, including consistency across laboratories and translation to clinical populations, have triggered efforts to harmonize methodologies. This includes the first set of preclinical common data elements (CDEs) for epilepsy r...

Full description

Saved in:
Bibliographic Details
Main Authors: Lisa Coles, Patrick A. Forcelli, Karine Leclercq, Anna‐Maria Katsarou, Brian D. Klein, Heidrun Potschka, Rudiger Koehling, Lauren Harte‐Hargrove, Aristea S. Galanopoulou, Cameron S. Metcalf
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:Epilepsia Open
Subjects:
Online Access:https://doi.org/10.1002/epi4.12721
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849224392780808192
author Lisa Coles
Patrick A. Forcelli
Karine Leclercq
Anna‐Maria Katsarou
Brian D. Klein
Heidrun Potschka
Rudiger Koehling
Lauren Harte‐Hargrove
Aristea S. Galanopoulou
Cameron S. Metcalf
author_facet Lisa Coles
Patrick A. Forcelli
Karine Leclercq
Anna‐Maria Katsarou
Brian D. Klein
Heidrun Potschka
Rudiger Koehling
Lauren Harte‐Hargrove
Aristea S. Galanopoulou
Cameron S. Metcalf
author_sort Lisa Coles
collection DOAJ
description Abstract Growing concerns over rigor and reproducibility of preclinical studies, including consistency across laboratories and translation to clinical populations, have triggered efforts to harmonize methodologies. This includes the first set of preclinical common data elements (CDEs) for epilepsy research studies, as well as Case Report Forms (CRFs) for widespread use in epilepsy research. The General Pharmacology Working Group of the ILAE/AES Task Force (TASK3‐WG1A) has continued in this effort by adapting and refining CDEs/CRFs to address specific study design areas as they relate to preclinical drug screening: general pharmacology, pharmacokinetics (PK) and pharmacodynamics (PD), and tolerability. This work has expanded general pharmacology studies to include dose records, PK/PD, tolerability, and elements of rigor and reproducibility. Tolerability testing CRFs included rotarod and Irwin/Functional Observation Battery (FOB) assays. The material provided in the form of CRFs can be delivered for widespread use within the epilepsy research community.
format Article
id doaj-art-c012fbfdabad4fa894f47076f4a48484
institution Kabale University
issn 2470-9239
language English
publishDate 2025-08-01
publisher Wiley
record_format Article
series Epilepsia Open
spelling doaj-art-c012fbfdabad4fa894f47076f4a484842025-08-25T10:12:58ZengWileyEpilepsia Open2470-92392025-08-0110S1S9S1710.1002/epi4.12721Preclinical common data elements for general pharmacological studies (pharmacokinetic sample collection, tolerability, and drug administration). A report of the TASK3‐WG1A General Pharmacology Working Group of the ILAE/AES Joint Translational Task ForceLisa Coles0Patrick A. Forcelli1Karine Leclercq2Anna‐Maria Katsarou3Brian D. Klein4Heidrun Potschka5Rudiger Koehling6Lauren Harte‐Hargrove7Aristea S. Galanopoulou8Cameron S. Metcalf9Department of Experimental and Clinical Pharmacology The University of Minnesota, College of Pharmacy Minneapolis Minnesota USADepartment of Pharmacology & Physiology Georgetown University Washington District of Columbia USAEarly Solutions Department UCB Pharma Braine‐l'Alleud BelgiumLaboratory of Developmental Epilepsy, Saul R. Korey Department of Neurology Albert Einstein College of Medicine Bronx New York USANational Institute of Neurological Disorders and Stroke, National Institutes of Health Bethesda Maryland USAInstitute of Pharmacology, Toxicology, and Pharmacy Ludwig‐Maximilians‐University Munich GermanyOscar‐Langendorff‐Institute of Physiology Rostock University Medical Center Rostock GermanyCURE Epilepsy Chicago Illinois USAIsabelle Rapin Division of Child Neurology, Saul R. Korey Department of Neurology Albert Einstein College of Medicine Bronx New York USADepartment of Pharmacology and Toxicology The University of Utah, College of Pharmacy Salt Lake City Utah USAAbstract Growing concerns over rigor and reproducibility of preclinical studies, including consistency across laboratories and translation to clinical populations, have triggered efforts to harmonize methodologies. This includes the first set of preclinical common data elements (CDEs) for epilepsy research studies, as well as Case Report Forms (CRFs) for widespread use in epilepsy research. The General Pharmacology Working Group of the ILAE/AES Task Force (TASK3‐WG1A) has continued in this effort by adapting and refining CDEs/CRFs to address specific study design areas as they relate to preclinical drug screening: general pharmacology, pharmacokinetics (PK) and pharmacodynamics (PD), and tolerability. This work has expanded general pharmacology studies to include dose records, PK/PD, tolerability, and elements of rigor and reproducibility. Tolerability testing CRFs included rotarod and Irwin/Functional Observation Battery (FOB) assays. The material provided in the form of CRFs can be delivered for widespread use within the epilepsy research community.https://doi.org/10.1002/epi4.12721animal modelcase report formcommon data elementpharmacologypreclinical
spellingShingle Lisa Coles
Patrick A. Forcelli
Karine Leclercq
Anna‐Maria Katsarou
Brian D. Klein
Heidrun Potschka
Rudiger Koehling
Lauren Harte‐Hargrove
Aristea S. Galanopoulou
Cameron S. Metcalf
Preclinical common data elements for general pharmacological studies (pharmacokinetic sample collection, tolerability, and drug administration). A report of the TASK3‐WG1A General Pharmacology Working Group of the ILAE/AES Joint Translational Task Force
Epilepsia Open
animal model
case report form
common data element
pharmacology
preclinical
title Preclinical common data elements for general pharmacological studies (pharmacokinetic sample collection, tolerability, and drug administration). A report of the TASK3‐WG1A General Pharmacology Working Group of the ILAE/AES Joint Translational Task Force
title_full Preclinical common data elements for general pharmacological studies (pharmacokinetic sample collection, tolerability, and drug administration). A report of the TASK3‐WG1A General Pharmacology Working Group of the ILAE/AES Joint Translational Task Force
title_fullStr Preclinical common data elements for general pharmacological studies (pharmacokinetic sample collection, tolerability, and drug administration). A report of the TASK3‐WG1A General Pharmacology Working Group of the ILAE/AES Joint Translational Task Force
title_full_unstemmed Preclinical common data elements for general pharmacological studies (pharmacokinetic sample collection, tolerability, and drug administration). A report of the TASK3‐WG1A General Pharmacology Working Group of the ILAE/AES Joint Translational Task Force
title_short Preclinical common data elements for general pharmacological studies (pharmacokinetic sample collection, tolerability, and drug administration). A report of the TASK3‐WG1A General Pharmacology Working Group of the ILAE/AES Joint Translational Task Force
title_sort preclinical common data elements for general pharmacological studies pharmacokinetic sample collection tolerability and drug administration a report of the task3 wg1a general pharmacology working group of the ilae aes joint translational task force
topic animal model
case report form
common data element
pharmacology
preclinical
url https://doi.org/10.1002/epi4.12721
work_keys_str_mv AT lisacoles preclinicalcommondataelementsforgeneralpharmacologicalstudiespharmacokineticsamplecollectiontolerabilityanddrugadministrationareportofthetask3wg1ageneralpharmacologyworkinggroupoftheilaeaesjointtranslationaltaskforce
AT patrickaforcelli preclinicalcommondataelementsforgeneralpharmacologicalstudiespharmacokineticsamplecollectiontolerabilityanddrugadministrationareportofthetask3wg1ageneralpharmacologyworkinggroupoftheilaeaesjointtranslationaltaskforce
AT karineleclercq preclinicalcommondataelementsforgeneralpharmacologicalstudiespharmacokineticsamplecollectiontolerabilityanddrugadministrationareportofthetask3wg1ageneralpharmacologyworkinggroupoftheilaeaesjointtranslationaltaskforce
AT annamariakatsarou preclinicalcommondataelementsforgeneralpharmacologicalstudiespharmacokineticsamplecollectiontolerabilityanddrugadministrationareportofthetask3wg1ageneralpharmacologyworkinggroupoftheilaeaesjointtranslationaltaskforce
AT briandklein preclinicalcommondataelementsforgeneralpharmacologicalstudiespharmacokineticsamplecollectiontolerabilityanddrugadministrationareportofthetask3wg1ageneralpharmacologyworkinggroupoftheilaeaesjointtranslationaltaskforce
AT heidrunpotschka preclinicalcommondataelementsforgeneralpharmacologicalstudiespharmacokineticsamplecollectiontolerabilityanddrugadministrationareportofthetask3wg1ageneralpharmacologyworkinggroupoftheilaeaesjointtranslationaltaskforce
AT rudigerkoehling preclinicalcommondataelementsforgeneralpharmacologicalstudiespharmacokineticsamplecollectiontolerabilityanddrugadministrationareportofthetask3wg1ageneralpharmacologyworkinggroupoftheilaeaesjointtranslationaltaskforce
AT laurenhartehargrove preclinicalcommondataelementsforgeneralpharmacologicalstudiespharmacokineticsamplecollectiontolerabilityanddrugadministrationareportofthetask3wg1ageneralpharmacologyworkinggroupoftheilaeaesjointtranslationaltaskforce
AT aristeasgalanopoulou preclinicalcommondataelementsforgeneralpharmacologicalstudiespharmacokineticsamplecollectiontolerabilityanddrugadministrationareportofthetask3wg1ageneralpharmacologyworkinggroupoftheilaeaesjointtranslationaltaskforce
AT cameronsmetcalf preclinicalcommondataelementsforgeneralpharmacologicalstudiespharmacokineticsamplecollectiontolerabilityanddrugadministrationareportofthetask3wg1ageneralpharmacologyworkinggroupoftheilaeaesjointtranslationaltaskforce